EPA:SAN - FR0000120578 - Common Stock
We assign a fundamental rating of 6 out of 10 to SAN. SAN was compared to 50 industry peers in the Pharmaceuticals industry. SAN scores excellent on profitability, but there are some minor concerns on its financial health. SAN has a decent growth rate and is not valued too expensively. SAN also has an excellent dividend rating. These ratings would make SAN suitable for dividend investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.05% | ||
ROE | 19.73% | ||
ROIC | 13.84% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 23.59% | ||
PM (TTM) | 20.35% | ||
GM | 71.7% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.21 | ||
Debt/FCF | 2.21 | ||
Altman-Z | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.27 | ||
Quick Ratio | 0.94 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.19 | ||
Fwd PE | 9.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 20.46 | ||
EV/EBITDA | 10.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.48% |
EPA:SAN (8/29/2025, 7:00:00 PM)
84.49
-0.87 (-1.02%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.48% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 11.19 | ||
Fwd PE | 9.69 | ||
P/S | 3.04 | ||
P/FCF | 20.46 | ||
P/OCF | 18.11 | ||
P/B | 2.94 | ||
P/tB | 22.17 | ||
EV/EBITDA | 10.97 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 11.05% | ||
ROE | 19.73% | ||
ROCE | 16.7% | ||
ROIC | 13.84% | ||
ROICexc | 16.48% | ||
ROICexgc | 66.95% | ||
OM | 23.59% | ||
PM (TTM) | 20.35% | ||
GM | 71.7% | ||
FCFM | 14.83% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.21 | ||
Debt/FCF | 2.21 | ||
Debt/EBITDA | 0.75 | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | 250 | ||
Cash Conversion | 58.05% | ||
Profit Quality | 72.91% | ||
Current Ratio | 1.27 | ||
Quick Ratio | 0.94 | ||
Altman-Z | N/A |